Peer Reviewed by Social Media
Clinical research and social media have a bizarre relationship, a complex interdependence that we have yet to fully understand. The ...
A Matter of Good Faith
The Supreme Court has agreed to clarify the question of good faith as it pertains to physician prescribing behavior. In ...
Pandemic Policy Reversals were Predicted
The pandemic has been characterized by poorly conceived policies and their inevitable reversals - with subsequent public outrage. However, these ...
Medical Data vs. Medical Necessity
This far into the pandemic, most have become aware of data's influence in deriving policy. But using data to make ...
American Individualism, Healthcare Externalities
Individualism has been the defining feature of American culture. Yet, as we enter into a post-pandemic world in which healthcare ...
Journalists Decide When COVID-19 Ends
The public's fascination with COVID-19 began with the attention journalists gave to it. But now that public interest in the ...
Direct to Consumer Chronic Care Management
Trends in healthcare market forces have predicted new startup business models, including the early success of direct to consumer models ...
Of Policies and Uncertainties
The US Preventive Services Task Force recently changed its guidance on aspirin as a preventative medication, a major policy shift. ...
America’s Medical Civil War
The Affordable Care Act has redefined federalism in America by creating new mechanisms for the state and nation to provide ...
When Data Becomes Due Process
Prosecutors often use patient data to investigate physicians. But patient data is biased, lacking the robustness required of evidence. And ...
COVID Vaccines for Kids
COVID-19 vaccines have been approved for children ages 5-11, a decision most had already anticipated. But lost in the predictability ...
America United International, Protecting Individuals Against Judicial Misconduct
Dr. Zena Crenshaw-Logal has taken what she learned as an advocate for judicial reform to launch America United International.
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more